Advanced Breast Cancer - Globe Thesis

Keyword [Advanced Breast Cancer] Result: 161 - 178 \| Page: 9 of 9
161.	Evaluation Of Therapeutic Effect Of Liver Regulating,kidney Tonifying And Accumulation Eliminating Therapy On Advanced Breast Cancer And Study On Inhibition Of Invasion And Migration Of Breast Cancer By Curdione
162.	Clinical Study Of Ruyan Fang Combined With Endocrine Therapy On Advanced Hormone Receptor-positive Advanced Breast Cancer(Hepatic Stagnation And Spleen Deficiency Type)
163.	Clinical Study Of Yanghe Huayan Decoction In The Treatment Of Advanced Breast Cancer
164.	The Analysis Of Survival And The Fragmentation Patterns Of Urinary Cell-free DNA Of Metastatic Breast Cancer Patients
165.	Effect Of Immunotherapy Combined With Metronomic Chemotherapy On Advanced Breast Cancer And Its Influence On Immune Environment
166.	Cancer/Testis Antigen MAGEC2 Promotes Resistance To CDK4/6 Inhibitors In HR+/HER2- Breast Cancer By Activating PI3K/AKT/mTOR Pathway
167.	Effect Of Capecitabine Metronome Chemotherapy In Hormone Receptor Positive Advanced Breast Cancer
168.	Clinical Efficacy And Adverse Reactions Of Apatinib In Patients With Advanced Breast Cancer
169.	Prognostic Analysis Of Dual-Target Therapy For Advanced Breast Cancer And Correlation Study Of ESR And CRP
170.	Predictive Value Of HER2 Low Expression On The Outcome And Recurrence Of Metastasis In Triple Negative Early/locally Advanced Breast Cancer Patients
171.	Correlation Study On The Changes Of Id-1 And MMP-9 Before And After Neoadjuvant Therapy For Breast Cancer
172.	A Real-world Study Of Pyrotinib In The Treatment Of HER2-positive Advanced Breast Cancer
173.	CDK4/6 Inhibitors Combined With Endocrine Therapy For Advanced Breast Cancer Clinical Study On Efficacy And Safety
174.	Single-Center Retrospective Study Of Pyrotinib Therapy In The Treatment Of HER-2-Positive Advanced Breast Cancer
175.	Meta-analysis Of The Efficacy And Safety Of VEGFR-TKIs In The Treatment Of Advanced Breast Cancer
176.	Efficacy Analysis Of Trastuzumab Combined With Pertuzumab In The Third-Line Treatment Of HER2-Positive Breast Cancer And The Value Of SOX11 In Predicting Its Efficacy
177.	Efficacy And Influence Factors Of Fulvestrant Monotherapy/Combination Treatment For Hormone Receptor-Positive Advanced Breast Cancer
178.	Correlation Analysis Between Systemic Inflammatory Markers And Pathological Complete Response In Locally Advanced Breast
<<First <Prev Next> Last>> Jump to